- €11.71bn
- €17.68bn
- €12.36bn
- 38
- 70
- 95
- 80
2019 December 31st | R2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 24,160 | 21,556 | 23,530 | 11,032 | 12,356 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21,864 | 18,613 | 20,989 | 10,384 | 10,824 |
Operating Profit | 2,296 | 2,943 | 2,541 | 648 | 1,532 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 2,429 | 2,196 | 3,832 | 648 | 1,532 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,985 | 1,811 | 3,163 | 540 | 1,184 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,962 | 1,904 | 3,278 | 1,634 | 1,172 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,903 | 1,845 | 3,219 | 1,576 | 1,121 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.6 | 6.87 | 10.2 | -1.25 | 3.75 |
Dividends per Share |